-glucosidase and -amylase inhibitory activity of flavonols from (Burm.f.) Bedd.

Rudi Hendra, Monika Kerry Army, Neni Frimayanti, Hilwan Yuda Teruna, Rizky Abdulah, Ari Satia Nugraha
Author Information
  1. Rudi Hendra: Department of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Riau, Pekanbaru, Indonesia.
  2. Monika Kerry Army: Department of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Riau, Pekanbaru, Indonesia.
  3. Neni Frimayanti: Sekolah Tinggi Ilmu Farmasi Riau, Pekanbaru, Indonesia.
  4. Hilwan Yuda Teruna: Department of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Riau, Pekanbaru, Indonesia.
  5. Rizky Abdulah: Center of Excellence in Pharmaceutical Care Innovation, Universitas Padjadjaran, Bandung, Indonesia.
  6. Ari Satia Nugraha: Drug Utilisation and Discovery Research Group, Faculty of Pharmacy, University of Jember, Jember, Indonesia.

Abstract

(Burm.f.) Bedd., a fern species native to India, Southeast Asia, Polynesia, and Australia, has a long history of medical including as a diabetic therapy. This study aimed to isolate bioactive compounds from ethyl acetate extract and assess their and inhibitory activities against -glucosidase and -amylase. The successful separation of five flavonols, namely stenopalustroside A (), tiliroside (), kaempferol (), quercetin (), and rutin (), was achieved through phytochemical analysis. The compounds exhibited a range of inhibitory activities against -glucosidase and -amylase, with IC values ranging from 40 to 250 µg/mL. Notably, the biological activities of compound have been reported for the first time. Compound was the most effective inhibitor of both enzymes among the isolated compounds. Studies performed reveal that the interactions between amino acids in compounds and are remarkably comparable to those observed in the positive control. These compounds share this commonality, and as a result, they both have the potential to be active agents.

Keywords

References

  1. Biology (Basel). 2020 Aug 28;9(9): [PMID: 32872226]
  2. Phytochemistry. 2021 Aug;188:112795 [PMID: 34044297]
  3. J Nat Prod. 2017 Jul 28;80(7):2141-2145 [PMID: 28682615]
  4. Clin Sci (Lond). 2021 Feb 12;135(4):613-627 [PMID: 33491733]
  5. J Nat Prod. 1999 Jan;62(1):70-5 [PMID: 9917285]
  6. Heliyon. 2022 Mar 04;8(3):e09045 [PMID: 35287328]
  7. Diabetes Metab Syndr Obes. 2012;5:357-67 [PMID: 23093911]
  8. J Enzyme Inhib Med Chem. 2019 Dec;34(1):577-588 [PMID: 30724629]
  9. Molecules. 2022 Jul 15;27(14): [PMID: 35889399]
  10. BMC Complement Altern Med. 2019 Dec 13;19(1):368 [PMID: 31836013]
  11. Plants (Basel). 2023 Jul 23;12(14): [PMID: 37514347]
  12. Bioorg Chem. 2018 Sep;79:257-264 [PMID: 29778797]
  13. J Enzyme Inhib Med Chem. 2017 Dec;32(1):1216-1228 [PMID: 28933564]
  14. Pharm Biol. 2018 Dec;56(1):18-24 [PMID: 29233045]
  15. Phytochemistry. 2014 Feb;98:27-33 [PMID: 24388677]
  16. Adv Pharmacol Pharm Sci. 2022 Nov 1;2022:5729217 [PMID: 36389123]
  17. Food Chem. 2015 Nov 1;186:26-31 [PMID: 25976787]
  18. Metabolites. 2023 Apr 03;13(4): [PMID: 37110171]

Word Cloud

Created with Highcharts 10.0.0compoundsinhibitoryactivities-glucosidase-amylaseBurmfBeddflavonolsfernspeciesnativeIndiaSoutheastAsiaPolynesiaAustralialonghistorymedicalincludingdiabetictherapystudyaimedisolatebioactiveethylacetateextractassesssuccessfulseparationfivenamelystenopalustrosidetilirosidekaempferolquercetinrutinachievedphytochemicalanalysisexhibitedrangeICvaluesranging40250 µg/mLNotablybiologicalcompoundreportedfirsttimeCompoundeffectiveinhibitorenzymesamongisolatedStudiesperformedrevealinteractionsaminoacidsremarkablycomparableobservedpositivecontrolsharecommonalityresultpotentialactiveagentsactivityFlavonolssilicoStenochlaenapalustrisα-glucosidaseα-amylaseinhibition

Similar Articles

Cited By